The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Towards Better Definition, Quantification and Treatment of Fibrosis in Heart Failure. A Scientific Roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
Open accessAbstract
Fibrosis is a pivotal player in heart failure development and progression. Measurements of (markers of) fibrosis in tissue and blood may help to diagnose and risk stratify patients with heart failure, and its treatment may be effective in preventing heart failure and its progression. A lack of pathophysiological insights and uniform definitions has hampered the research in fibrosis and heart failure. The Translational Research Committee of the Heart Failure Association discussed several aspects of fibrosis in their workshop. Early insidious perturbations such as subclinical hypertension or inflammation may trigger first fibrotic events, while more dramatic triggers such as myocardial infarction and myocarditis give rise to full blown scar formation and ongoing fibrosis in diseased hearts. Aging itself is also associated with a cardiac phenotype that includes fibrosis. Fibrosis is an extremely heterogeneous phenomenon, as several stages of the fibrotic process exist, each with different fibrosis subtypes and a different composition of various cells and proteins — resulting in a very complex pathophysiology. As a result, detection of fibrosis, e.g. using current cardiac imaging modalities or plasma biomarkers, will detect only specific subforms of fibrosis, but cannot capture all aspects of the complex fibrotic process. Furthermore, several anti-fibrotic therapies are under investigation, but such therapies generally target aspecific aspects of the fibrotic process and suffer from a lack of precision. This review discusses the mechanisms and the caveats and proposes a roadmap for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Self-citationThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Gulati, A., Jabbour, A., Ismail, T. F., Guha, K., Khwaja, J., Raza, S., Morarji, K., Brown, T. D. H., Ismail, N. A., Dweck, M. R., et al. (2013) · JAMA · doi:10.1001/jama.2013.1363 · Cited by 1,179
Self-citationPhenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap
Shah, S. J., Kitzman, D. W., Borlaug, B. A., van Heerebeek, L., Zile, M. R., Kass, D. A., & Paulus, W. J. (2016) · Circulation · doi:10.1161/circulationaha.116.021884 · Cited by 1,003
Sharma, U. C., Pokharel, S., van Brakel, T. J., van Berlo, J. H., Cleutjens, J. P. M., Schroen, B., André, S., Crijns, H. J. G. M., Gabius, H. J., Maessen, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000147181.65298.4d · Cited by 947
Bozkurt, B., Kribbs, S. B., Clubb, F. J., Michael, L. H., Didenko, V. V., Hornsby, P. J., Seta, Y., Oral, H., Spinale, F. G., & Mann, D. L. (1998) · Circulation · doi:10.1161/01.cir.97.14.1382 · Cited by 821
Iles, L., Pfluger, H., Phrommintikul, A., Cherayath, J., Aksit, P., Gupta, S. N., Kaye, D. M., & Taylor, A. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.049 · Cited by 736
Horckmans, M., Ring, L., Duchene, J., Santovito, D., Schloss, M. J., Drechsler, M., Weber, C., Soehnlein, O., & Steffens, S. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw002 · Cited by 727
Myocardial Interstitial Fibrosis in Heart Failure
González, A., Schelbert, E. B., Díez, J., & Butler, J. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.021 · Cited by 660
Lipson, K. E., Wong, C., Teng, Y., & Spong, S. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s24 · Cited by 575
Self-citationGalectin-3: A Novel Mediator of Heart Failure Development and Progression
de Boer, R. A., Voors, A. A., Muntendam, P., van Gilst, W. H., & van Veldhuisen, D. J. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp097 · Cited by 524
Self-citationFibroblasts in myocardial infarction: A role in inflammation and repair
Shinde, A. V., & Frangogiannis, N. G. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.015 · Cited by 522
Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
MacKinnon, A. C., Gibbons, M. A., Farnworth, S. L., Leffler, H., Nilsson, U. J., Delaine, T., Simpson, A. J., Forbes, S. J., Hirani, N., Gauldie, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0965oc · Cited by 516
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm456 · Cited by 464
Basic mechanisms in heart failure: The cytokine hypothesis
Seta, Y., Shan, K., Bozkurt, B., Oral, H., & Mann, D. L. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80047-9 · Cited by 444
Yu, L., Ruifrok, W. P. T., Meissner, M., Bos, E. M., van Goor, H., Sanjabi, B., van der Harst, P., Pitt, B., Goldstein, I. J., Koerts, J. A., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.971168 · Cited by 435
Self-citationMolecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
Creemers, E. E., & Pinto, Y. M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq308 · Cited by 403
Myocardial Fibrosis: Biomedical Research from Bench to Bedside
Gyöngyösi, M., Winkler, J., Ramos, I., Do, Q.-T., Firat, H., McDonald, K., González, A., Thum, T., Díez, J., Jaisser, F., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.696 · Cited by 397
Self-citationMyocardial Extracellular Matrix: An Ever-Changing and Diverse Entity
Rienks, M., Papageorgiou, A.-P., Frangogiannis, N. G., & Heymans, S. (2014) · Circulation Research · doi:10.1161/circresaha.114.302533 · Cited by 366
Self-citationGalectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Calvier, L., Miana, M., Reboul, P., Cachofeiro, V., Martinez-Martinez, E., de Boer, R. A., Poirier, F., Lacolley, P., Zannad, F., Rossignol, P., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300569 · Cited by 359
Self-citationJun, J.-I., & Lau, L. F. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93563 · Cited by 345
Piccoli, M.-T., Gupta, S. K., Viereck, J., Foinquinos, A., Samolovac, S., Kramer, F. L., Garg, A., Remke, J., Zimmer, K., Batkai, S., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310624 · Cited by 344
Self-citationCardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease
Dai, D.-F., Chen, T., Johnson, S. C., Szeto, H., & Rabinovitch, P. S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4179 · Cited by 334
Ali, S. R., Ranjbarvaziri, S., Talkhabi, M., Zhao, P., Subat, A., Hojjat, A., Kamran, P., Müller, A. M. S., Volz, K. S., Tang, Z., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303794 · Cited by 309
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Suthahar, N., Meijers, W. C., Silljé, H. H. W., Ho, J. E., Liu, F.-T., & de Boer, R. A. (2018) · Theranostics · doi:10.7150/thno.22196 · Cited by 309
Self-citationSuthahar, N., Meijers, W. C., Silljé, H. H. W., & de Boer, R. A. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0343-y · Cited by 307
T1 Mapping in Cardiomyopathy at Cardiac MR: Comparison with Endomyocardial Biopsy
Sibley, C. T., Noureldin, R. A., Gai, N., Nacif, M. S., Liu, S., Turkbey, E. B., Mudd, J. O., van der Geest, R. J., Lima, J. A. C., Halushka, M. K., et al. (2012) · Radiology · doi:10.1148/radiol.12112721 · Cited by 303
Origin of Cardiac Fibroblasts and the Role of Periostin
Snider, P., Standley, K. N., Wang, J., Azhar, M., Doetschman, T., & Conway, S. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.201400 · Cited by 302
The fibrosis-cell death axis in heart failure
Piek, A., de Boer, R. A., & Silljé, H. H. W. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9536-9 · Cited by 301
Self-citationGrotendorst, G. R., Rahmanie, H., & Duncan, M. R. (2004) · The FASEB Journal · doi:10.1096/fj.03-0699com · Cited by 291
Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling
Horn, M. A., & Trafford, A. W. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.005 · Cited by 275
Iraqi, W., Rossignol, P., Angioi, M., Fay, R., Nuée, J., Ketelslegers, J. M., Vincent, J., Pitt, B., & Zannad, F. (2009) · Circulation · doi:10.1161/circulationaha.108.809194 · Cited by 260
Self-citationCirculating Biomarkers of Myocardial Fibrosis
López, B., González, A., Ravassa, S., Beaumont, J., Moreno, M. U., San José, G., Querejeta, R., & Díez, J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.026 · Cited by 258
Strutz, F., Zeisberg, M., Renziehausen, A., Raschke, B., Becker, V., Van Kooten, C., & Müller, G. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002579.x · Cited by 250
Essential role for premature senescence of myofibroblasts in myocardial fibrosis
Meyer, K., Hodwin, B., Ramanujam, D., Engelhardt, S., & Sarikas, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.047 · Cited by 247
Tillmanns, J., Hoffmann, D., Habbaba, Y., Schmitto, J. D., Sedding, D., Fraccarollo, D., Galuppo, P., & Bauersachs, J. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.08.016 · Cited by 237
Self-citationCMR-Verified Diffuse Myocardial Fibrosis Is Associated With Diastolic Dysfunction in HFpEF
Su, M.-Y. M., Lin, L.-Y., Tseng, Y.-H. E., Chang, C.-C., Wu, C.-K., Lin, J.-L., & Tseng, W.-Y. I. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.04.022 · Cited by 229
Rommel, K.-P., von Roeder, M., Latuscynski, K., Oberueck, C., Blazek, S., Fengler, K., Besler, C., Sandri, M., Lücke, C., Gutberlet, M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.018 · Cited by 208
Ma, Y., Halade, G. V., Zhang, J., Ramirez, T. A., Levin, D., Voorhees, A., Jin, Y.-F., Han, H.-C., Manicone, A. M., & Lindsey, M. L. (2013) · Circulation Research · doi:10.1161/circresaha.111.300502 · Cited by 206
Self-citationFrantz, S., Hofmann, U., Fraccarollo, D., Schäfer, A., Kranepuhl, S., Hagedorn, I., Nieswandt, B., Nahrendorf, M., Wagner, H., Bayer, B., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-214049 · Cited by 195
Self-citationState of the Art: Newer Biomarkers in Heart Failure
de Boer, R. A., Daniels, L. B., Maisel, A. S., & Januzzi, J. L. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.273 · Cited by 188
Self-citationAmeri, P., Canepa, M., Anker, M. S., Belenkov, Y., Bergler-Klein, J., Cohen-Solal, A., Farmakis, D., López-Fernández, T., Lainscak, M., Pudil, R., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1165 · Cited by 185
Self-citationHeart Failure With Preserved Ejection Fraction: Molecular Pathways of the Aging Myocardium
Loffredo, F. S., Nikolova, A. P., Pancoast, J. R., & Lee, R. T. (2014) · Circulation Research · doi:10.1161/circresaha.115.302929 · Cited by 182
Lindsey, M. L., Mayr, M., Gomes, A. V., Delles, C., Arrell, D. K., Murphy, A. M., Lange, R. A., Costello, C. E., Jin, Y.-F., Laskowitz, D. T., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000226 · Cited by 175
Self-citationExtracellular Matrix Secretion by Cardiac Fibroblasts: Role of MicroRNA-29b and MicroRNA-30c
Abonnenc, M., Nabeebaccus, A. A., Mayr, U., Barallobre-Barreiro, J., Dong, X., Cuello, F., Sur, S., Drozdov, I., Langley, S. R., Lu, R., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.302400 · Cited by 168
Self-citationKulasekaran, P., Scavone, C. A., Rogers, D. S., Arenberg, D. A., Thannickal, V. J., & Horowitz, J. C. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0447oc · Cited by 161
Krämer, J., Niemann, M., Liu, D., Hu, K., Machann, W., Beer, M., Wanner, C., Ertl, G., & Weidemann, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht098 · Cited by 151
Role and New Insights of Pirfenidone in Fibrotic Diseases
la Mora, D. A. L.-D., Sánchez-Roque, C., Montoya‐Buelna, M., Sánchez‐Enríquez, S., Lucano‐Landeros, S., Macías‐Barragán, J., & Armendáriz‐Borunda, J. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.11579 · Cited by 150
Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4
Díez, J., González, A., & Kovacic, J. C. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.019 · Cited by 150
The role of inflammatory and fibrogenic pathways in heart failure associated with aging
Chen, W., & Frangogiannis, N. G. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9161-y · Cited by 148
Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities
Cuijpers, I., Simmonds, S. J., van Bilsen, M., Czarnowska, E., González, A., Heymans, S. R. B., Kuhn, A.-R., Mulder, P. G. H., Ratajska, A., Jones, E. A. V., et al. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0798-y · Cited by 146
Self-citationSearching for New Mechanisms of Myocardial Fibrosis with Diagnostic and/or Therapeutic Potential
Heymans, S. R. B., González, A., Pizard, A., Papageorgiou, A., López‐Andrés, N., Jaisser, F., Thum, T., Zannad, F. M., & Dı́ez, J. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.312 · Cited by 132
Self-citationAttenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA‐salt hypertensive rats
Mirkovic, S., Seymour, A. L., Fenning, A. S., Strachan, A. J., Margolin, S. B., Taylor, S. M., & Brown, L. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704539 · Cited by 129
Čelutkienė, J., Plymen, C. M., Flachskampf, F. A., de Boer, R. A., Grapsa, J., Manka, R., Anderson, L., Garbi, M., Barberis, V. I., Filardi, P. P., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1330 · Cited by 127
Self-citationNguyen, D. T., Ding, C., Wilson, E., Marcus, G. M., & Olgin, J. E. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.04.030 · Cited by 126
Matrix metalloproteinases and myocardial infarction
Phatharajaree, W., Phrommintikul, A., & Chattipakorn, N. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70818-8 · Cited by 123
Bondue, A., Arbustini, E., Bianco, A., Ciccarelli, M., Dawson, D. K., Rosa, M. D., Hamdani, N., Hilfiker‐Kleiner, D., Meder, B., Leite-Moreira, A. F., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy122 · Cited by 108
Self-citationIyer, R. P., Patterson, N. L., Zouein, F. A., Ma, Y., Dive, V., Brás, L. E. D. C., & Lindsey, M. L. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.054 · Cited by 100
Self-citationPlasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Du, W., Piek, A., Schouten, E. M., van de Kolk, C. W. A., Mueller, C. E., Mebazaa, A., Voors, A. A., de Boer, R. A., & Silljé, H. H. W. (2018) · Theranostics · doi:10.7150/thno.26055 · Cited by 100
Extracellular matrix fibrotic markers in heart failure
Zannad, F. M., Rossignol, P., & Iraqi, W. (2009) · Heart Failure Reviews · doi:10.1007/s10741-009-9143-0 · Cited by 99
Self-citationAlmaas, V. M., Haugaa, K. H., Strøm, E. H., Scott, H., Smith, H., Dahl, C. P., Geiran, O. R., Endresen, K., Aakhus, S., Amlie, J., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304923 · Cited by 99
Yamagami, K., Oka, T., Wang, Q., Ishizu, T., Lee, J., Miwa, K., Akazawa, H., Naito, A. T., Sakata, Y., & Komuro, I. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00137.2015 · Cited by 97
Reversible and irreversible differentiation of cardiac fibroblasts
Driesen, R. B., Nagaraju, C. K., Abi-Char, J., Coenen, T., Lijnen, P. J., Fagard, R. H., Sipido, K. R., & Petrov, V. V. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt338 · Cited by 97
The role of inflammation in heart failure: new therapeutic approaches.
Oikonomou, E. K., Tousoulis, D., Siasos, G., Zaromitidou, M., Papavassiliou, A. G., & Stefanadis, C. (2011) · PubMed · Cited by 91
Szabó, Z., Magga, J. M., Alakoski, T., Ulvila, J., Piuhola, J., Vainio, L., Kivirikko, K. I., Vuolteenaho, O. J., Ruskoaho, H. J., Lipson, K. E., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03279 · Cited by 89
Self-citationSPARC mediates early extracellular matrix remodeling following myocardial infarction
McCurdy, S. M., Dai, Q., Zhang, J., Zamilpa, R., Ramirez, T. A., Dayah, T. J., Nguyen, N., Jin, Y.-F., Bradshaw, A. D., & Lindsey, M. L. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01070.2010 · Cited by 84
Self-citationVermeulen, Z., Hervent, A.-S., Dugaucquier, L., Vandekerckhove, L., Rombouts, M., Beyens, M., Schrijvers, D. M., Meyer, G. R. Y. D., Maudsley, S. R., Keulenaer, G. W. D., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00206.2017 · Cited by 83
Diastolic Dysfunction in the Elderly—The Interstitial Issue
Burlew, B. S. (2004) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2004.00059.x · Cited by 81
The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice
Yamazaki, T., Yamashita, N., Izumi, Y., Nakamura, Y., Shiota, M., Hanatani, A., Shimada, K., Muro, T., Iwao, H., & Yoshiyama, M. (2011) · Hypertension Research · doi:10.1038/hr.2011.139 · Cited by 71
Modifying the mechanics of healing infarcts: Is better the enemy of good?
Clarke, S. A., Richardson, W. J., & Holmes, J. W. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.028 · Cited by 71
Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation
Barallobre‐Barreiro, J., Gupta, S. K., Zoccarato, A., Kitazume-Taneike, R., Fava, M., Yin, X., Werner, T., Hirt, M. N., Zampetaki, A., Viviano, A., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.016423 · Cited by 71
Self-citationAlapati, D., Rong, M., Chen, S., Hehre, D., Rodriguez, M. M., Lipson, K. E., & WU, S. M. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0023oc · Cited by 69
Self-citationNew Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis
Ding, Q., Luckhardt, T., Hecker, L., Zhou, Y., Liu, G., Antony, V. B., deAndrade, J. A., & Thannickal, V. J. (2011) · Drugs · doi:10.2165/11591490-000000000-00000 · Cited by 64
Eijgenraam, T. R., Boukens, B. J., Boogerd, C. J. J., Schouten, E. M., van de Kolk, C. W. A., Stege, N. M., Rijdt, W. P. T., Hoorntje, E. T., van der Zwaag, P. A., van Rooij, E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66656-9 · Cited by 64
Molecular mechanism of imidapril for cardiovascular protection via inhibition of MMP-9
Yamamoto, D., Takai, S., Jin, D., Inagaki, S., Tanaka, K., & Miyazaki, M. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.002 · Cited by 62
Role of osteopontin in heart failure associated with aging
Singh, M., Foster, C. R., Dalal, S., & Singh, K. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9158-6 · Cited by 61
The aging hypertensive heart: a brief update
Sušić, D., & Frohlich, E. D. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1091 · Cited by 47
Weber, K. T., Sun, Y., & Dı́ez, J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.012 · Cited by 39
Pharmacological Implications of MMP-9 Inhibition by ACE Inhibitors
Yamamoto, D., & Takai, S. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787846514 · Cited by 35
The year in cardiology: heart failure
Cleland, J. G. F., Lyon, A. R., McDonagh, T. A., & McMurray, J. J. V. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz949 · Cited by 34
Self-citationCarluccio, E., Biagioli, P., Zuchi, C., Bardelli, G., Murrone, A., Lauciello, R., D’Addario, S., Mengoni, A., Alunni, G., & Ambrosio, G. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-0881-5 · Cited by 33
Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models
Deddens, J. C., Sadeghi, A. H., Hjortnaes, J., Laake, L. W. V., Buijsrogge, M. P., Doevendans, P. A., Khademhosseini, A., & Sluijter, J. P. G. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600571 · Cited by 33
Self-citationFibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue
Maione, A. S., Pilato, C. A., Casella, M., Gasperetti, A., Stadiotti, I., Pompilio, G., & Sommariva, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00279 · Cited by 30
Chang, S., Lee, S., Choe, Y. H., Hahn, H. J., Jang, S. Y., Park, S. J., Choi, J., Park, S. W., & Oh, J. K. (2012) · International journal of cardiac imaging · doi:10.1007/s10554-012-0141-2 · Cited by 29
Kosla, J., Dvořáková, M., Dvořák, M., & Čermák, V. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.10.013 · Cited by 27
Li, X., Tang, X., Lu, J., & Yuan, S. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8323 · Cited by 26
Sorting out where fibroblasts come from
Moore-Morris, T., Tallquist, M., & Evans, S. M. (2014) · Circulation Research · doi:10.1161/circresaha.114.304854 · Cited by 15
Good at Heart: Preserving Cardiac Metabolism during aging
Sorriento, D., Franco, A., Rusciano, M. R., Maione, A. S., Soprano, M., Illario, M., Iaccarino, G., & Ciccarelli, M. (2015) · Current Diabetes Reviews · doi:10.2174/1573399811666150722124958 · Cited by 7
Cited by
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
López, B., Ravassa, S., Moreno, M. U., José, G. S., Beaumont, J., González, A., & Díez, J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00504-1 · Cited by 361
Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Sun, B., Wu, L., Wu, Y., Zhang, C., Qin, L., Hayashi, M., Kudo, M., Gao, M., & Liu, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568032 · Cited by 353
Common risk factors for heart failure and cancer
Meijers, W. C., & de Boer, R. A. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz035 · Cited by 314
Self-citationWithaar, C., Meems, L. M. G., Markousis-Mavrogenis, G., Boogerd, C. J., Silljé, H. H. W., Schouten, E. M., Dokter, M. M., Voors, A. A., Westenbrink, B. D., Lam, C. S. P., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa256 · Cited by 223
Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles
Evers, M. J. W., Du, W., Yang, Q., Kooijmans, S. A. A., Vink, A., van Steenbergen, M., Vader, P., de Jager, S. C. A., Fuchs, S. A., Mastrobattista, E., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.027 · Cited by 113
Self-citation
Metadata
- Authors
- de Boer, R. A., De Keulenaer, G., Bauersachs, J., Brutsaert, D., Cleland, J. G., Diez, J., Du, X.-J., Ford, P., Heinzel, F. R., Lipson, K. E., McDonagh, T., Lopez-Andres, N., Lunde, I. G., Lyon, A. R., Pollesello, P., Prasad, S. K., Tocchetti, C. G., Mayr, M., Sluijter, J. P. G., Thum, T., Tschöpe, C., Zannad, F., Zimmermann, W.-H., Ruschitzka, F., Filippatos, G., Lindsey, M. L., Maack, C., & Heymans, S.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-02-04
- Volume
- 21
- Issue
- 3
- Pages
- 272-285
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2912308947
- Cited by
- 304
- References
- 91
- FWCI
- 24.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.